×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Faculty of Healt... [5]
Authors
ZHAO QI [3]
Document Type
Journal article [5]
Date Issued
2022 [2]
2015 [2]
2014 [1]
Language
英語English [5]
Source Publication
Antibodies [1]
MAbs [1]
MedComm [1]
PLoS One [1]
mAbs [1]
Indexed By
ESCI [2]
SCIE [1]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-5 of 5
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
Quantitation and Identification of Therapeutic Anti-CD22 Monoclonal Antibodies in a Cell-Based ELISA Method
Journal article
Fu, Shengyu, Zhao, Qi. Quantitation and Identification of Therapeutic Anti-CD22 Monoclonal Antibodies in a Cell-Based ELISA Method[J]. Antibodies, 2022, 11(3), 53.
Authors:
Fu, Shengyu
;
Zhao, Qi
Favorite
|
TC[WOS]:
0
TC[Scopus]:
0
IF:
3.0
/
4.7
|
Submit date:2022/08/27
Cd22
Elisa
Monoclonal Antibodies
Programmed death-ligand 1 expression on CD22-specific chimeric antigen receptor-modified T cells weakens antitumor potential
Journal article
Liu, Jie, Zhang, Fengjuan, Yu, Jian, Zhao, Qi. Programmed death-ligand 1 expression on CD22-specific chimeric antigen receptor-modified T cells weakens antitumor potential[J]. MedComm, 2022, 3(2).
Authors:
Liu, Jie
;
Zhang, Fengjuan
;
Yu, Jian
;
Zhao, Qi
Favorite
|
TC[WOS]:
4
TC[Scopus]:
3
|
Submit date:2022/08/02
Car-t
Cd22
Immune Checkpoint
Pd-l1
Surrogate target cells expressing surface anti-idiotype antibody for the clinical evaluation of an internalizing CD22-specific antibody
Journal article
Leung, S., Gao, K., Wang, G., Cheung, B., Lee, K., Zhao, Q., Cheung, W., Wang, J.. Surrogate target cells expressing surface anti-idiotype antibody for the clinical evaluation of an internalizing CD22-specific antibody[J]. MAbs, 2015, 66-76.
Authors:
Leung, S.
;
Gao, K.
;
Wang, G.
;
Cheung, B.
;
Lee, K.
; et al.
Favorite
|
IF:
5.6
/
5.8
|
Submit date:2023/08/30
CD22
internalizing
anti-idiotype
surrogate target cells
bioassay
Surrogate target cells expressing surface anti-idiotype antibody for the clinical evaluation of an internalizing CD22-specific antibody
Journal article
Leung S.-O., Gao K., Wang G.Y., Cheung B.K.-W., Lee K.-Y., Zhao Q., Cheung W.-T., Wang J.Z.. Surrogate target cells expressing surface anti-idiotype antibody for the clinical evaluation of an internalizing CD22-specific antibody[J]. mAbs, 2015, 7(1), 66-76.
Authors:
Leung S.-O.
;
Gao K.
;
Wang G.Y.
;
Cheung B.K.-W.
;
Lee K.-Y.
; et al.
Favorite
|
TC[WOS]:
4
TC[Scopus]:
5
|
Submit date:2019/01/16
Anti-idiotype
Bioassay
Cd22
Internalizing
Surrogate Target Cells
Generation of anti-idiotype scFv for pharmacokinetic measurement in lymphoma patients treated with chimera anti-CD22 antibody SM03
Journal article
Zhao, Q., Wong, P., Lee, S., Leung, S., Cheung, W., Wang, J.. Generation of anti-idiotype scFv for pharmacokinetic measurement in lymphoma patients treated with chimera anti-CD22 antibody SM03[J]. PLoS One, 2014, e96697-e96697.
Authors:
Zhao, Q.
;
Wong, P.
;
Lee, S.
;
Leung, S.
;
Cheung, W.
; et al.
Favorite
|
IF:
2.9
/
3.3
|
Submit date:2023/08/30
CD22
idiotype scFv
antibody
lymphoma